PharmaPoint: Ulcerative Colitis – Canada Drug Forecast and Market Analysis to 2022 Summary During the forecast period from 2012-2022, the growth of the UC market will be driven largely by the entry of Johnson & Johnson’s (J&J’s) Simponi and Takeda’s […]
February 2014 Life Science Industry Research Reports
PharmaPoint: Ulcerative Colitis – Japan Drug Forecast and Market Analysis to 2022
PharmaPoint: Ulcerative Colitis – Japan Drug Forecast and Market Analysis to 2022 Summary During the forecast period from 2012-2022, the growth of the UC market will be driven largely by the entry of Johnson & Johnson’s (J&J’s) Simponi and Takeda’s […]
PharmaPoint: Ulcerative Colitis – 5EU Drug Forecast and Market Analysis to 2022
PharmaPoint: Ulcerative Colitis – 5EU Drug Forecast and Market Analysis to 2022 Summary During the forecast period from 2012-2022, the growth of the UC market will be driven largely by the entry of Johnson & Johnson’s (J&J’s) Simponi and Takeda’s […]
PharmaPoint: Ulcerative Colitis – US Drug Forecast and Market Analysis to 2022
PharmaPoint: Ulcerative Colitis – US Drug Forecast and Market Analysis to 2022 Summary During the forecast period from 2012-2022, the growth of the UC market will be driven largely by the entry of Johnson & Johnson’s (J&J’s) Simponi and Takeda’s […]
PharmaPoint: Ulcerative Colitis – Current and Future Players
PharmaPoint: Ulcerative Colitis – Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Ulcerative Colitis – Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the […]
EVP-6124 (Schizophrenia) – Forecast and Market Analysis to 2022
Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, auditory or visual hallucinations, are often accompanied by fixed, false, and often paranoid beliefs, called delusions. These two features are often combined with learning […]
Bitopertin (Schizophrenia) – Forecast and Market Analysis to 2022
Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, auditory or visual hallucinations, are often accompanied by fixed, false, and often paranoid beliefs, called delusions. These two features are often combined with learning […]
Zicronapine (Schizophrenia) – Forecast and Market Analysis to 2022
Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, auditory or visual hallucinations, are often accompanied by fixed, false, and often paranoid beliefs, called delusions. These two features are often combined with learning […]
Brexpiprazole (Schizophrenia) – Forecast and Market Analysis to 2022
Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, auditory or visual hallucinations, are often accompanied by fixed, false, and often paranoid beliefs, called delusions. These two features are often combined with learning […]
Cariprazine (Schizophrenia) – Forecast and Market Analysis to 2022
Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, auditory or visual hallucinations, are often accompanied by fixed, false, and often paranoid beliefs, called delusions. These two features are often combined with learning […]